Medpace is a full-service global Clinical Research Organization (CRO) focused on phase I, II, and III clinical research, carrying a well-established reputation in the pharmaceuticals industry. Operating from Cincinnati, Ohio, in the United States, Medpace's reach is extensive, with office locations spanning six continents. The company also maintains global central laboratory, imaging core laboratory, and bioanalytical laboratory services, further enhancing its comprehensive capabilities.
Medpace prides itself in a research approach that blends high science with regulatory and therapeutic expertise across all major therapeutic areas. This comprehensive approach allows the company to handle the manifold challenges that arise during clinical trials, ensuring sponsors can count on a collaborative team of medical, operational, and regulatory experts with in-depth insight about the disease and patients the trial focuses on.
The company's services include early phase clinical research, late phase clinical research, medical device & diagnostics, regulatory affairs, medical writing, clinical monitoring, clinical trial management, biostatistics & data sciences, drug safety & pharmacovigilance, quality assurance, imaging, ECG core labs, and clinical development in areas such as oncology, nephrology, neuroscience, infectious diseases, cardiovascular, metabolic & endocrine, and rare diseases, amongst others. In addition, the company is armed with services tailored to newer fields such as cell & gene therapy clinical development.
Promising a rewarding experience, Medpace offers exposure to various aspects of clinical research, planning processes behind clinical trials and leveraging insights from data to create comprehensive visualizations and metrics. This balance of breadth and depth amasses to show why Medpace is trusted by Biotech, not only for delivering expectations in service but also for being a venue for personal and professional development in the industry.
With an estimated workforce of 5400 employees, Medpace is proactively committed to making a difference in the future of clinical and regulatory services, inviting those interested in exploring career opportunities to join the cause.
Before initiating an outreach, it is imperative to have a thorough understanding of the potential client's business. In our case, the company is Medpace, a global full-service clinical research organization spanning six continents with a wide range of services such as early to late phase clinical research, regulatory affairs, clinical trial management, biostatistics & data sciences, medical writing, drug safety & pharmacovigilance, among others. Medpace employs a high-science, disciplined operating approach and promotes an integrated, global approach to clinical development.
Medpace's diverse operations and global reach come with their unique set of challenges. The following have been identified as potential pain points:
Our SaaS solution can address the identified pain points of Medpace by:
The initial outreach to Medpace should be personalized, addressing their specific pain points, and clearly stating how our solution can help. It is crucial to communicate our value proposition effectively.
Post the initial outreach, follow-up actions should be planned. Understand their initial reactions and queries, further clarify doubts, and engage them with demos, webinars, case studies, and client testimonials to substantiate our claims.
After successful engagement and demonstration of the potential value our solution can deliver, negotiation around pricing and terms of service will ensue. Upon reaching an agreeable term, move forward to closure, ensuring a smooth onboarding process for Medpace.
[^2^]: Medpace | LinkedIn
[^3^]: Medpace - Wikipedia
[^5^]: Contact | Medpace